BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 17151933)

  • 1. Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker.
    Saito T; Arifin MT; Hama S; Kajiwara Y; Sugiyama K; Yamasaki F; Hidaka T; Arita K; Kurisu K
    J Neurooncol; 2007 Apr; 82(2):193-8. PubMed ID: 17151933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
    Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
    Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nuclear and cytoplasmic expressions of survivin in glioma and their prognostic value].
    Pan Y; Hu WH; Xie D; Wu QL; Liu YH; Xiang J; Wu HX
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):325-9. PubMed ID: 17456361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of low cytoplasmic and high nuclear expression of p27 predicts a better prognosis in high-grade astrocytoma.
    Hidaka T; Hama S; Shrestha P; Saito T; Kajiwara Y; Yamasaki F; Sugiyama K; Kurisu K
    Anticancer Res; 2009 Feb; 29(2):597-603. PubMed ID: 19331209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide.
    Saito T; Sugiyama K; Takeshima Y; Amatya VJ; Yamasaki F; Takayasu T; Nosaka R; Muragaki Y; Kawamata T; Kurisu K
    J Neurosurg; 2018 Mar; 128(3):679-684. PubMed ID: 28430038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nuclear expression of Survivin in glioma and its correlation to prognosis].
    Pan Y; Hu WH; Xie D; Wu HX; Xiang J; Liu YD; Wu QL; Liu YH
    Ai Zheng; 2006 May; 25(5):635-9. PubMed ID: 16687089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
    Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 expression and subcellular survivin localization improve the diagnosis and prognosis of patients with diffuse astrocytic tumors.
    Faccion RS; Bernardo PS; de Lopes GPF; Bastos LS; Teixeira CL; de Oliveira JA; Fernandes PV; Dubois LG; Chimelli L; Maia RC
    Cell Oncol (Dordr); 2018 Apr; 41(2):141-157. PubMed ID: 29374392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index.
    Uematsu M; Ohsawa I; Aokage T; Nishimaki K; Matsumoto K; Takahashi H; Asoh S; Teramoto A; Ohta S
    J Neurooncol; 2005 May; 72(3):231-8. PubMed ID: 15937645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of nuclear DJ-1 expression in astrocytoma.
    Miyajima Y; Sato Y; Oka H; Utsuki S; Kondo K; Tanizaki Y; Nagashio R; Tsuchiya B; Okayasu I; Fujii K
    Anticancer Res; 2010 Jan; 30(1):265-9. PubMed ID: 20150646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic, but not nuclear, p16 expression may signal poor prognosis in high-grade astrocytomas.
    Arifin MT; Hama S; Kajiwara Y; Sugiyama K; Saito T; Matsuura S; Yamasaki F; Arita K; Kurisu K
    J Neurooncol; 2006 May; 77(3):273-7. PubMed ID: 16614947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
    Bria E; Visca P; Novelli F; Casini B; Diodoro MG; Perrone-Donnorso R; Botti C; Sperduti I; Facciolo F; Milella M; Cecere FL; Cognetti F; Mottolese M
    Eur J Surg Oncol; 2008 May; 34(5):593-8. PubMed ID: 17693049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.
    Grabowski P; Griss S; Arnold CN; Hörsch D; Göke R; Arnold R; Heine B; Stein H; Zeitz M; Scherübl H
    Neuroendocrinology; 2005; 81(1):1-9. PubMed ID: 15809513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin, caspase-3 and MIB-1 expression in astrocytic tumors of various grades.
    Lebelt A; Rutkowski R; Och W; Jaczun K; Dziemiańczyk-Pakieła D; Milewski R; Mariak Z; Reszeć J
    Adv Med Sci; 2016 Sep; 61(2):237-243. PubMed ID: 26995334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer.
    Brennan DJ; Rexhepaj E; O'Brien SL; McSherry E; O'Connor DP; Fagan A; Culhane AC; Higgins DG; Jirstrom K; Millikan RC; Landberg G; Duffy MJ; Hewitt SM; Gallagher WM
    Clin Cancer Res; 2008 May; 14(9):2681-9. PubMed ID: 18451232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients.
    Hinnis AR; Luckett JC; Walker RA
    Br J Cancer; 2007 Feb; 96(4):639-45. PubMed ID: 17285125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth?
    Moon WS; Tarnawski AS
    Hum Pathol; 2003 Nov; 34(11):1119-26. PubMed ID: 14652813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma.
    Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Masumori N; Sato N; Tsukamoto T
    Virchows Arch; 2013 Jan; 462(1):101-7. PubMed ID: 23179762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma.
    Shinohara ET; Gonzalez A; Massion PP; Chen H; Li M; Freyer AS; Olson SJ; Andersen JJ; Shyr Y; Carbone DP; Johnson DH; Hallahan DE; Lu B
    Cancer; 2005 Apr; 103(8):1685-92. PubMed ID: 15742356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.